Correlation Between 23Andme Holding and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and X4 Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and X4 Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and X4 Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and XFOR is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and X4 Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the X4 Pharmaceuticals. In addition to that, 23Andme Holding is 1.05 times more volatile than X4 Pharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest 80.00 in X4 Pharmaceuticals on December 27, 2024 and sell it today you would lose (53.00) from holding X4 Pharmaceuticals or give up 66.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. X4 Pharmaceuticals
Performance |
Timeline |
23Andme Holding |
X4 Pharmaceuticals |
23Andme Holding and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and X4 Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges |